{"id":4675,"date":"2015-08-24T17:04:36","date_gmt":"2015-08-24T15:04:36","guid":{"rendered":"https:\/\/celonpharma.com\/?p=4675"},"modified":"2017-11-17T09:34:04","modified_gmt":"2017-11-17T09:34:04","slug":"celon-pharma-at-the-european-hematology-association-congress","status":"publish","type":"post","link":"https:\/\/celonpharma.com\/en\/celon-pharma-at-the-european-hematology-association-congress\/","title":{"rendered":"Celon Pharma at the European Hematology Association Congress"},"content":{"rendered":"<p>Among the participants of the 20th European Hematology Association (EHA) Congress which took place on 11-14 June in Vienna were also representatives of Celon Pharma S.A.<\/p>\n<p>This year, the Company presented the latest results of research on the development of potential drugs for treatment of leukemias and lymphomas. The data was presented in the form of a poster entitled &#8220;Design and development of a novel, highly potent and selective PI3K-delta inhibitor, CPL-302-215, as potential treatment of hematologic malignancies&#8221;.<\/p>\n<p>During last year&#8217;s Congress, which was held in Italy, Celon Pharma presented the latest results of research on developing PI3K-delta inhibitors.<\/p>\n<p>The European Hematology Association (EHA) Congress is an event which promotes the idea of improving patient care, research and education on hematology in Europe.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Among the participants of the 20th European Hematology Association (EHA) Congress which took place on 11-14 June in Vienna were also representatives of Celon Pharma S.A. This year, the Company presented the latest results of research on the development of potential drugs for treatment of leukemias and lymphomas. The data was presented in the form<a class=\"excerpt-read-more float-right\" href=\"https:\/\/celonpharma.com\/en\/celon-pharma-at-the-european-hematology-association-congress\/\" title=\"ReadCelon Pharma at the European Hematology Association Congress\">Read more &raquo;<\/a><\/p>\n","protected":false},"author":11,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[27],"tags":[],"class_list":["post-4675","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Celon Pharma at the European Hematology Association Congress - Celon Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/celonpharma.com\/en\/celon-pharma-at-the-european-hematology-association-congress\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Celon Pharma at the European Hematology Association Congress - Celon Pharma\" \/>\n<meta property=\"og:description\" content=\"Among the participants of the 20th European Hematology Association (EHA) Congress which took place on 11-14 June in Vienna were also representatives of Celon Pharma S.A. This year, the Company presented the latest results of research on the development of potential drugs for treatment of leukemias and lymphomas. The data was presented in the formRead more &raquo;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/celonpharma.com\/en\/celon-pharma-at-the-european-hematology-association-congress\/\" \/>\n<meta property=\"og:site_name\" content=\"Celon Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2015-08-24T15:04:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2017-11-17T09:34:04+00:00\" \/>\n<meta name=\"author\" content=\"S\u0142awomir Ni\u017cnik\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"S\u0142awomir Ni\u017cnik\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-at-the-european-hematology-association-congress\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-at-the-european-hematology-association-congress\\\/\"},\"author\":{\"name\":\"S\u0142awomir Ni\u017cnik\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/44c54386ed112173d6e8bcbeb6425338\"},\"headline\":\"Celon Pharma at the European Hematology Association Congress\",\"datePublished\":\"2015-08-24T15:04:36+00:00\",\"dateModified\":\"2017-11-17T09:34:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-at-the-european-hematology-association-congress\\\/\"},\"wordCount\":136,\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-at-the-european-hematology-association-congress\\\/\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-at-the-european-hematology-association-congress\\\/\",\"name\":\"Celon Pharma at the European Hematology Association Congress - Celon Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\"},\"datePublished\":\"2015-08-24T15:04:36+00:00\",\"dateModified\":\"2017-11-17T09:34:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/44c54386ed112173d6e8bcbeb6425338\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-at-the-european-hematology-association-congress\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-at-the-european-hematology-association-congress\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-at-the-european-hematology-association-congress\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Celon Pharma at the European Hematology Association Congress\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\",\"name\":\"Celon Pharma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/44c54386ed112173d6e8bcbeb6425338\",\"name\":\"S\u0142awomir Ni\u017cnik\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Celon Pharma at the European Hematology Association Congress - Celon Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/celonpharma.com\/en\/celon-pharma-at-the-european-hematology-association-congress\/","og_locale":"en_US","og_type":"article","og_title":"Celon Pharma at the European Hematology Association Congress - Celon Pharma","og_description":"Among the participants of the 20th European Hematology Association (EHA) Congress which took place on 11-14 June in Vienna were also representatives of Celon Pharma S.A. This year, the Company presented the latest results of research on the development of potential drugs for treatment of leukemias and lymphomas. The data was presented in the formRead more &raquo;","og_url":"https:\/\/celonpharma.com\/en\/celon-pharma-at-the-european-hematology-association-congress\/","og_site_name":"Celon Pharma","article_published_time":"2015-08-24T15:04:36+00:00","article_modified_time":"2017-11-17T09:34:04+00:00","author":"S\u0142awomir Ni\u017cnik","twitter_card":"summary_large_image","twitter_misc":{"Written by":"S\u0142awomir Ni\u017cnik","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/celonpharma.com\/en\/celon-pharma-at-the-european-hematology-association-congress\/#article","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/celon-pharma-at-the-european-hematology-association-congress\/"},"author":{"name":"S\u0142awomir Ni\u017cnik","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/44c54386ed112173d6e8bcbeb6425338"},"headline":"Celon Pharma at the European Hematology Association Congress","datePublished":"2015-08-24T15:04:36+00:00","dateModified":"2017-11-17T09:34:04+00:00","mainEntityOfPage":{"@id":"https:\/\/celonpharma.com\/en\/celon-pharma-at-the-european-hematology-association-congress\/"},"wordCount":136,"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/celonpharma.com\/en\/celon-pharma-at-the-european-hematology-association-congress\/","url":"https:\/\/celonpharma.com\/en\/celon-pharma-at-the-european-hematology-association-congress\/","name":"Celon Pharma at the European Hematology Association Congress - Celon Pharma","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/#website"},"datePublished":"2015-08-24T15:04:36+00:00","dateModified":"2017-11-17T09:34:04+00:00","author":{"@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/44c54386ed112173d6e8bcbeb6425338"},"breadcrumb":{"@id":"https:\/\/celonpharma.com\/en\/celon-pharma-at-the-european-hematology-association-congress\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/celonpharma.com\/en\/celon-pharma-at-the-european-hematology-association-congress\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/celonpharma.com\/en\/celon-pharma-at-the-european-hematology-association-congress\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celonpharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"Celon Pharma at the European Hematology Association Congress"}]},{"@type":"WebSite","@id":"https:\/\/celonpharma.com\/en\/#website","url":"https:\/\/celonpharma.com\/en\/","name":"Celon Pharma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celonpharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/44c54386ed112173d6e8bcbeb6425338","name":"S\u0142awomir Ni\u017cnik"}]}},"_links":{"self":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/4675","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/comments?post=4675"}],"version-history":[{"count":1,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/4675\/revisions"}],"predecessor-version":[{"id":12088,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/4675\/revisions\/12088"}],"wp:attachment":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/media?parent=4675"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/categories?post=4675"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/tags?post=4675"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}